O Prof. Sadi Kerem Okutur tem mais de 13 anos de especialização em oncologia médica, com foco no cancro da próstata no Hospital Memorial Bahçelievler.

• Professor associado com vasta investigação em oncologia
• Publicação de mais de 20 artigos e 10 capítulos de livros
• Vencedor do Prémio de Investigação em Oncologia 2012
• Membro da Sociedade Europeia de Oncologia Médica
• Especialização em diagnóstico e planos de tratamento abrangentes

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

O médico formou-se na Faculdade de Medicina da Universidade de Ancara e completou a residência em medicina interna na Faculdade de Medicina de Ancara GATA. Especializando-se em oncologia médica e hematologia, o médico completou uma bolsa clínica nos EUA. Pioneiro na Turquia, o médico fez parte da equipe que realizou o primeiro transplante de medula óssea no país. O médico atuou como professor visitante em instituições de prestígio em Londres e Suíça. Detentor do Certificado Europeu de Oncologia Médica, o médico é membro fundador tanto da Sociedade Turca de Oncologia Médica quanto do Grupo Oncológico Turco. O foco clínico inclui câncer de mama, gastrointestinal, pulmão, linfomas e mieloma.<\/p>

Mais de 900 tratamentos oncológicos realizados – O Prof. Sezer Saglam é especialista em terapias direcionadas para o cancro da próstata no Hospital Florence Nightingale de Istambul.

• 28 anos de experiência em oncologia médica
• Professor desde 2016 com investigações que influenciam protocolos globais
• Membro da ASCO, ESMO e da European Neuroendocrine Tumour Society
• Liderar ensaios clínicos em medicina de precisão para oncologia
• Utilizar exames GA68 PET PSMA para planos de tratamento personalizados

O Dr. Tahsin Ozadli realizou mais de 1.100 tratamentos como oncologista clínico, com vasta experiência em casos de cancro da próstata.

• 21 anos de experiência em oncologia médica
• Especializado em cancro da próstata no Hospital de Oncologia de Ancara
• Perfil do Google Scholar que mostra investigação ativa em oncologia
• Trabalhar especificamente nos Hospitais Valued Med Hub

O Dr. Topcu formou-se em centros de oncologia de topo em todo o mundo, incluindo o MD Anderson e o Moffitt Cancer Center, concentrando-se em vários tipos de cancro, incluindo o cancro da próstata.

• Especializar-se em Oncologia Médica na Universidade Técnica de Karadeniz
• Ter experiência no tratamento de uma vasta gama de condições oncológicas
• Trabalhar em vários hospitais de prestígio a nível mundial
• Ser membro de várias equipas internacionais de investigação sobre o cancro

O Dr. Selami Albayrak é especializado em urologia no Hospital Universitário Medipol Mega.

• Praticar com foco em casos de cancro da próstata
• Trabalhar num hospital universitário líder em Istambul
• Dedicar-se à prestação de cuidados urológicos centrados no paciente

O Dr. Yildiz publicou extensivamente sobre o cancro da próstata e outras condições oncológicas, com investigação apresentada em revistas internacionais revistas por pares.

• Especializar-se em tumores neuroendócrinos e casos oncológicos complexos
• Publicar mais de 17 artigos revistos por pares sobre vários tipos de cancro
• Trabalhar no Hospital Universitário Medipol Mega
• Abranger experiência desde o diagnóstico até protocolos de tratamento avançados

O Professor Associado Tahsin Ozatli especializa-se no tratamento do cancro da próstata no Hospital Liv da Universidade de Istinye, Bahcesehir.

• Especialista em Medicina Interna com anos de experiência
• Antigo médico na Clínica de Oncologia de Ancara
• Formação concluída na Faculdade de Medicina da Universidade de Selcuk
• Promovido a Professor Associado em 2016

O Professor Cemil Bilir combina a perícia académica em oncologia médica com formação internacional – incluindo investigação na Northeastern University, em Boston.

• Especializado em oncologia médica com mais de 13 anos de experiência
• Membro da ASCO, ESMO e TTOD – principais sociedades de oncologia
• Professor atual na Faculdade de Medicina da Universidade de Sakarya
• Formado na Cleveland Clinic em reumatologia e gastroenterologia

O Prof. Nail Paksoy é especialista no tratamento do cancro da próstata no Hospital Medipol Bahçelievler, com certificação da ESMO em Oncologia Médica.

• Concluir a especialização em oncologia médica no Instituto de Oncologia da Universidade de Istambul
• Publicar investigação sobre a carga tumoral baseada em PSMA no cancro da próstata
• Participar em ensaios clínicos internacionais para tratamentos oncológicos avançados
• Ser certificado pela ESMO em Oncologia Médica desde 2022

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

O Dr. Ozden traz mais de 20 anos de experiência médica, especializando-se no tratamento do cancro da próstata no Hospital VM Medical Park Pendik.

• Licenciado pela prestigiada Faculdade de Medicina Cerrahpaşa da Universidade de Istambul
• Subespecialização em oncologia médica concluída na Universidade de Kocaeli
• Vasta experiência em medicina interna antes de se focar na oncologia

O Professor Gul Alco é especialista em radioterapia oncológica para cancro da próstata na Universidade Medipol de Istambul.

• Mais de 20 anos de experiência em radioterapia oncológica
• Professor Associado e posteriormente Professor na Universidade Demiroglu Bilim
• Residência concluída na Universidade Kadir Has
• Trabalhar no Hospital Distrital Medipol Acibadem

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

O Professor Serkan Deveci lidera a urologia no Medical Park Göztepe, tendo publicado mais de 30 artigos de investigação sobre resultados no cancro da próstata.

• Especializado em prostatectomia assistida por robô e técnicas de preservação nervosa
• Membro da American Urology Association e da Associação Turca de Urologia
• Editor de secção para o conteúdo de urologia da UpToDate – confiado por médicos em todo o mundo
• 621 citações atestam o impacto da sua investigação no tratamento do cancro da próstata

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.

Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
Autologous bone marrow mesenchymal Cellular
Male-Shot

​

After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments

His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement   Penile Implants , Penile Enhancement , SafeFill and MaleShot  into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.

(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)

​

Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.

​

​

OTHER AREAS OF FOCUS

Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male infertility, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder botox injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, Fertility preservation, Minimally invasive surgery, Hypospadias

​

Membership of Scientific Organizations

Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Stem Cells Applications

• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en

​